| scholarly article | Q13442814 |
| P50 | author | Sean Davis | Q37390205 |
| Frederic G. Barr | Q112547144 | ||
| Charles Keller | Q41575258 | ||
| P2093 | author name string | Javed Khan | |
| Qing-Rong Chen | |||
| Mario R Capecchi | |||
| Paul S Meltzer | |||
| Ranadip Pal | |||
| Benjamin R Arenkiel | |||
| Jinu Abraham | |||
| Yidong Chen | |||
| Brian P Rubin | |||
| David M Parham | |||
| Hung-I Harry Chen | |||
| Lee Ann Zarzabal | |||
| Joel E Michalek | |||
| Koichi Nishijo | |||
| Zhongxin Yu | |||
| Suresh I Prajapati | |||
| Amanda T McCleish | |||
| Xiaolan Yi | |||
| David P Schuetze | |||
| P2860 | cites work | PAX7 expression in embryonal rhabdomyosarcoma suggests an origin in muscle satellite cells | Q24651250 |
| PRDM16 controls a brown fat/skeletal muscle switch | Q24657178 | ||
| Global gene expression profiling of PAX-FKHR fusion-positive alveolar and PAX-FKHR fusion-negative embryonal rhabdomyosarcomas | Q28300128 | ||
| Mouse tumor model for neurofibromatosis type 1 | Q28591456 | ||
| Asymmetric self-renewal and commitment of satellite stem cells in muscle. | Q30489194 | ||
| Malignant fibrous histiocytoma: an ultrastructural perspective | Q30934141 | ||
| Expression of CD34 and Myf5 defines the majority of quiescent adult skeletal muscle satellite cells | Q33928516 | ||
| A Postnatal Pax7 Progenitor Gives Rise to Pituitary Adenomas. | Q34094915 | ||
| Trends in childhood rhabdomyosarcoma incidence and survival in the United States, 1975-2005 | Q34192795 | ||
| Germline p53 mutations are frequently detected in young children with rhabdomyosarcoma | Q34207682 | ||
| Two cell lineages, myf5 and myf5-independent, participate in mouse skeletal myogenesis | Q34760457 | ||
| Continuous myofiber remodeling in uninjured extraocular myofibers: myonuclear turnover and evidence for apoptosis. | Q35633086 | ||
| Examination of gene fusion status in archival samples of alveolar rhabdomyosarcoma entered on the Intergroup Rhabdomyosarcoma Study-III trial: a report from the Children's Oncology Group | Q35790146 | ||
| A comparison of MyoD1 and fetal acetylcholine receptor expression in childhood tumors and normal tissues: implications for the molecular diagnosis of minimal disease in rhabdomyosarcomas | Q35869185 | ||
| Pax3 and Pax7 have distinct and overlapping functions in adult muscle progenitor cells. | Q36116755 | ||
| Rb is required for progression through myogenic differentiation but not maintenance of terminal differentiation. | Q36321999 | ||
| Significance of persistent mature rhabdomyoblasts in bladder/prostate rhabdomyosarcoma: Results from IRS IV. | Q36605836 | ||
| Molecular classification of rhabdomyosarcoma--genotypic and phenotypic determinants of diagnosis: a report from the Children's Oncology Group | Q37071890 | ||
| Biomarker system for studying muscle, stem cells, and cancer in vivo. | Q37280794 | ||
| Prevalence and clinical impact of anaplasia in childhood rhabdomyosarcoma : a report from the Soft Tissue Sarcoma Committee of the Children's Oncology Group | Q37307376 | ||
| Cooperation of oncogenic K-ras and p53 deficiency in pleomorphic rhabdomyosarcoma development in adult mice | Q79755825 | ||
| Identification of a hypaxial somite enhancer element regulating Pax3 expression in migrating myoblasts and characterization of hypaxial muscle Cre transgenic mice | Q81571797 | ||
| Muscling in: Uncovering the origins of rhabdomyosarcoma | Q82793750 | ||
| Diagnosing alveolar rhabdomyosarcoma: morphology must be coupled with fusion confirmation | Q83946958 | ||
| Alveolar rhabdomyosarcomas in conditional Pax3:Fkhr mice: cooperativity of Ink4a/ARF and Trp53 loss of function. | Q37598848 | ||
| Effects of RAS on the genesis of embryonal rhabdomyosarcoma. | Q38301662 | ||
| Constitutive properties, not molecular adaptations, mediate extraocular muscle sparing in dystrophic mdx mice | Q38356050 | ||
| Increased expression of the hedgehog signaling pathway in pediatric solid malignancies | Q39740299 | ||
| Nevoid basal-cell carcinoma syndrome | Q39759038 | ||
| RAS signaling dysregulation in human embryonal Rhabdomyosarcoma | Q39812687 | ||
| Immunohistochemical detection of EGFR, fibrillin-2, P-cadherin and AP2beta as biomarkers for rhabdomyosarcoma diagnostics | Q39976938 | ||
| The hedgehog regulated oncogenes Gli1 and Gli2 block myoblast differentiation by inhibiting MyoD-mediated transcriptional activation | Q40233567 | ||
| Identification of a PAX-FKHR gene expression signature that defines molecular classes and determines the prognosis of alveolar rhabdomyosarcomas | Q40254065 | ||
| An immunohistochemical algorithm to facilitate diagnosis and subtyping of rhabdomyosarcoma: the Children's Oncology Group experience | Q40304584 | ||
| Mutations of the PTPN11 and RAS genes in rhabdomyosarcoma and pediatric hematological malignancies | Q40308333 | ||
| Single-cell analysis of regulatory gene expression in quiescent and activated mouse skeletal muscle satellite cells | Q42448117 | ||
| Rhabdomyosarcomas and radiation hypersensitivity in a mouse model of Gorlin syndrome | Q42455110 | ||
| Case report: nasopharyngeal rhabdomyosarcoma and Gorlin's naevoid basal cell carcinoma syndrome | Q42465028 | ||
| Deregulation of the hedgehog signalling pathway: a possible role for the PTCH and SUFU genes in human rhabdomyoma and rhabdomyosarcoma development | Q42486654 | ||
| Rhabdomyosarcoma in children: epidemiologic study and identification of a familial cancer syndrome | Q44178518 | ||
| Prognostic factors and clinical outcomes in children and adolescents with metastatic rhabdomyosarcoma--a report from the Intergroup Rhabdomyosarcoma Study IV. | Q44265659 | ||
| p53 mutation and loss have different effects on tumourigenesis in a novel mouse model of pleomorphic rhabdomyosarcoma | Q46676622 | ||
| Altered expression and molecular abnormalities of cell-cycle-regulatory proteins in rhabdomyosarcoma | Q47733005 | ||
| Gene expression analysis of soft tissue sarcomas: characterization and reclassification of malignant fibrous histiocytoma. | Q48693168 | ||
| Secretin, a known gastrointestinal peptide, is widely expressed during mouse embryonic development. | Q49129948 | ||
| Intergroup Rhabdomyosarcoma Study: update for pathologists. | Q53349844 | ||
| Cytodifferentiation and clinical outcome after chemotherapy and radiation therapy for rhabdomyosarcoma (RMS). | Q53390484 | ||
| Detection of point mutations in N-ras and K-ras genes of human embryonal rhabdomyosarcomas using oligonucleotide probes and the polymerase chain reaction. | Q53512387 | ||
| Molecular signature of quiescent satellite cells in adult skeletal muscle. | Q53543981 | ||
| Fusion gene-negative alveolar rhabdomyosarcoma is clinically and molecularly indistinguishable from embryonal rhabdomyosarcoma. | Q54434638 | ||
| Alterations of RB1 gene in embryonal and alveolar rhabdomyosarcoma: special reference to utility of pRB immunoreactivity in differential diagnosis of rhabdomyosarcoma subtype. | Q54539055 | ||
| Growth mechanism of satellite cells in human urethral rhabdosphincter. | Q54559403 | ||
| Pax3:Foxc2 Reciprocal Repression in the Somite Modulates Muscular versus Vascular Cell Fate Choice in Multipotent Progenitors | Q57952102 | ||
| Skeletal Muscle Differentiation of Embryonic Mesoangioblasts Requires Pax3 Activity | Q59484949 | ||
| Risk of Soft Tissue Sarcomas by Individual Subtype in Survivors of Hereditary Retinoblastoma | Q61345540 | ||
| Childhood soft tissue sarcomas incidence and survival in European children (1978–1997): Report from the Automated Childhood Cancer Information System project | Q61625490 | ||
| Expression of the retinoblastoma susceptibility gene in childhood rhabdomyosarcomas | Q70525044 | ||
| Spindle cell variants of embryonal rhabdomyosarcoma in the paratesticular region. A report of the Intergroup Rhabdomyosarcoma Study | Q70564388 | ||
| Tissue-specific expression of SV40 in tumors associated with the Li-Fraumeni syndrome | Q74332896 | ||
| P433 | issue | 2 | |
| P921 | main subject | embryonal rhabdomyosarcoma | Q5370233 |
| P304 | page(s) | 177-191 | |
| P577 | publication date | 2011-02-01 | |
| P1433 | published in | Cancer Cell | Q280018 |
| P1476 | title | Evidence for an unanticipated relationship between undifferentiated pleomorphic sarcoma and embryonal rhabdomyosarcoma | |
| P478 | volume | 19 |
| Q39413508 | 18F-FDG microPET imaging detects early transient response to an IGF1R inhibitor in genetically engineered rhabdomyosarcoma models |
| Q36367000 | A Patient-Derived Xenograft Model of Parameningeal Embryonal Rhabdomyosarcoma for Preclinical Studies |
| Q36343292 | A mouse model of rhabdomyosarcoma originating from the adipocyte lineage. |
| Q38100823 | A myogenic precursor cell that could contribute to regeneration in zebrafish and its similarity to the satellite cell |
| Q35638688 | A series of Cre-ER(T2) drivers for manipulation of the skeletal muscle lineage |
| Q35408740 | A versatile modular vector system for rapid combinatorial mammalian genetics |
| Q35082747 | Acute tissue injury activates satellite cells and promotes sarcoma formation via the HGF/c-MET signaling pathway |
| Q57799916 | Analysis of the relationship between the KRAS G12V oncogene and the Hippo effector YAP1 in embryonal rhabdomyosarcoma |
| Q34235576 | Anaplastic rhabdomyosarcoma in TP53 germline mutation carriers |
| Q38855577 | Artesunate induces ROS- and p38 MAPK-mediated apoptosis and counteracts tumor growth in vivo in embryonal rhabdomyosarcoma cells |
| Q89722579 | CASZ1 induces skeletal muscle and rhabdomyosarcoma differentiation through a feed-forward loop with MYOD and MYOG |
| Q35729845 | CIITA is silenced by epigenetic mechanisms that prevent the recruitment of transactivating factors in rhabdomyosarcoma cells. |
| Q38215035 | Canonical and non-canonical Hedgehog signalling and the control of metabolism |
| Q38893243 | Cavin-1 and Caveolin-1 are both required to support cell proliferation, migration and anchorage-independent cell growth in rhabdomyosarcoma |
| Q89414511 | Cell growth potential drives ferroptosis susceptibility in rhabdomyosarcoma and myoblast cell lines |
| Q35847829 | Childhood rhabdomyosarcoma: recent advances and prospective views |
| Q38151409 | Classification of rhabdomyosarcoma and its molecular basis. |
| Q50027091 | Clinical and mutational spectrum of highly differentiated, paired box 3:forkhead box protein o1 fusion-negative rhabdomyosarcoma: A report from the Children's Oncology Group |
| Q37530309 | Conditional Loss of Pten in Myogenic Progenitors Leads to Postnatal Skeletal Muscle Hypertrophy but Age-Dependent Exhaustion of Satellite Cells. |
| Q28536066 | Cross-species array comparative genomic hybridization identifies novel oncogenic events in zebrafish and human embryonal rhabdomyosarcoma |
| Q38367725 | Decoding the 'embryonic' nature of embryonal rhabdomyosarcoma |
| Q34045952 | Development and potential applications of CRISPR-Cas9 genome editing technology in sarcoma |
| Q35148115 | Development of genetically flexible mouse models of sarcoma using RCAS-TVA mediated gene delivery |
| Q37881290 | Developmental origins of fusion-negative rhabdomyosarcomas. |
| Q41849189 | Distinct and overlapping sarcoma subtypes initiated from muscle stem and progenitor cells. |
| Q41917751 | Distinct cellular origin and genetic requirement of Hedgehog-Gli in postnatal rhabdomyosarcoma genesis |
| Q42160737 | Distinct malignant behaviors of mouse myogenic tumors induced by different oncogenetic lesions |
| Q38297328 | Distinct methylation profiles characterize fusion-positive and fusion-negative rhabdomyosarcoma. |
| Q36025454 | Dystrophin and dysferlin double mutant mice: a novel model for rhabdomyosarcoma |
| Q30426842 | Embryonic signaling pathways and rhabdomyosarcoma: contributions to cancer development and opportunities for therapeutic targeting |
| Q34795063 | Genomic signatures predict poor outcome in undifferentiated pleomorphic sarcomas and leiomyosarcomas |
| Q38874972 | HIF-1 Alpha Regulates the Response of Primary Sarcomas to Radiation Therapy through a Cell Autonomous Mechanism. |
| Q50116993 | Hedgehog Pathway Drives Fusion-Negative Rhabdomyosarcoma Initiated From Non-myogenic Endothelial Progenitors. |
| Q38834036 | Hedgehog/Patched-associated rhabdomyosarcoma formation from delta1-expressing mesodermal cells |
| Q36739725 | Hepatocyte Growth Factor-mediated satellite cells niche perturbation promotes development of distinct sarcoma subtypes |
| Q37294778 | Hypoxia-dependent modification of collagen networks promotes sarcoma metastasis. |
| Q39118373 | IL-4 receptor blockade abrogates satellite cell: rhabdomyosarcoma fusion and prevents tumor establishment. |
| Q41853105 | In vivo imaging of tumor-propagating cells, regional tumor heterogeneity, and dynamic cell movements in embryonal rhabdomyosarcoma |
| Q36503375 | Induction of a regenerative microenvironment in skeletal muscle is sufficient to induce embryonal rhabdomyosarcoma in p53-deficient mice |
| Q38637192 | Iron, Oxidative Damage and Ferroptosis in Rhabdomyosarcoma |
| Q35987311 | Kras activation in p53-deficient myoblasts results in high-grade sarcoma formation with impaired myogenic differentiation |
| Q30411722 | Lineage of origin in rhabdomyosarcoma informs pharmacological response |
| Q35667137 | MURC/cavin-4 Is Co-Expressed with Caveolin-3 in Rhabdomyosarcoma Tumors and Its Silencing Prevents Myogenic Differentiation in the Human Embryonal RD Cell Line |
| Q91932017 | Manipulating the tumour-suppressor protein Rb in lung cancer reveals possible drug targets |
| Q26852728 | Mechanisms of impaired differentiation in rhabdomyosarcoma |
| Q36402478 | Mouse models of sarcomas: critical tools in our understanding of the pathobiology |
| Q35832899 | Multiple sites of highly amplified DNA sequences detected by molecular cytogenetic analysis in HS-RMS-2, a new pleomorphic rhabdomyosarcoma cell line |
| Q37583178 | Myogenic regulatory transcription factors regulate growth in rhabdomyosarcoma |
| Q35913399 | Myogenic transcription factors regulate pro-metastatic miR-182. |
| Q41815541 | NF1 deletion generates multiple subtypes of soft-tissue sarcoma that respond to MEK inhibition. |
| Q41664774 | NFκB signaling in alveolar rhabdomyosarcoma |
| Q86615686 | Neonatal tumours |
| Q50804445 | New approaches for pediatric rhabdomyosarcoma drug discovery: targeting combinatorial signaling. |
| Q38248375 | New insights into signalling-pathway alterations in rhabdomyosarcoma |
| Q43239032 | New insights into the origin and the genetic basis of rhabdomyosarcomas. |
| Q39174563 | Oncogenic NRAS, required for pathogenesis of embryonic rhabdomyosarcoma, relies upon the HMGA2-IGF2BP2 pathway |
| Q37598768 | PAX3/7-FOXO1 fusion status in older rhabdomyosarcoma patient population by fluorescent in situ hybridization |
| Q37464647 | Phosphocaveolin-1 enforces tumor growth and chemoresistance in rhabdomyosarcoma. |
| Q42032454 | Preclinical testing of the glycogen synthase kinase-3β inhibitor tideglusib for rhabdomyosarcoma |
| Q36142754 | Probing for a deeper understanding of rhabdomyosarcoma: insights from complementary model systems. |
| Q38105879 | Proof-of-concept rare cancers in drug development: the case for rhabdomyosarcoma. |
| Q35987724 | Protein kinase C iota as a therapeutic target in alveolar rhabdomyosarcoma. |
| Q38733011 | RAS and ROS in rhabdomyosarcoma |
| Q55206301 | RETRACTED: Pediatric sarcomas. |
| Q34255856 | Rb1 loss modifies but does not initiate alveolar rhabdomyosarcoma |
| Q64056837 | Rhabdomyosarcoma and Wilms tumors contain a subpopulation of noggin producing, myogenic cells immunoreactive for lens beaded filament proteins |
| Q33800135 | Rhabdomyosarcoma in adolescent and young adult patients: current perspectives |
| Q26784207 | Rhabdomyosarcoma: Advances in Molecular and Cellular Biology |
| Q34400242 | Rhabdomyosarcoma: current challenges and their implications for developing therapies. |
| Q37973827 | Rhabdomyosarcomas: an overview on the experimental animal models. |
| Q35647795 | Sarcomas induced in discrete subsets of prospectively isolated skeletal muscle cells |
| Q92663085 | Serial Xenotransplantation in NSG Mice Promotes a Hybrid Epithelial/Mesenchymal Gene Expression Signature and Stemness in Rhabdomyosarcoma Cells |
| Q58707604 | Soft Tissue Sarcoma Cancer Stem Cells: An Overview |
| Q33734818 | TBX2 blocks myogenesis and promotes proliferation in rhabdomyosarcoma cells |
| Q41896211 | Targeting oxidative stress in embryonal rhabdomyosarcoma. |
| Q37879912 | The Hedgehog's tale: developing strategies for targeting cancer |
| Q35754387 | The Spindle Assembly Checkpoint Safeguards Genomic Integrity of Skeletal Muscle Satellite Cells |
| Q28081814 | The case for primary salivary rhabdomyosarcoma |
| Q84535956 | The long road to immunotherapy for childhood rhabdomyosarcoma |
| Q41575226 | The not-so-skinny on muscle cancer |
| Q38211082 | The role of inflammation in sarcoma |
| Q90364706 | Tumorsphere Derivation and Treatment from Primary Tumor Cells Isolated from Mouse Rhabdomyosarcomas |
| Q38553827 | Uncovering metabolism in rhabdomyosarcoma. |
| Q38487518 | Utilizing signature-score to identify oncogenic pathways of cholangiocarcinoma |
| Q33895506 | What is new in the biology and treatment of pediatric rhabdomyosarcoma? |
| Q58087058 | YAP1 enhances NF-κB-dependent and independent effects on clock-mediated unfolded protein responses and autophagy in sarcoma |
| Q53081286 | YAP1-Mediated Suppression of USP31 Enhances NFκB Activity to Promote Sarcomagenesis. |
| Q38831343 | Zebrafish Rhabdomyosarcoma |
| Q36975776 | Zebrafish rhabdomyosarcoma reflects the developmental stage of oncogene expression during myogenesis |
| Q64101372 | c-Myb regulates tumorigenic potential of embryonal rhabdomyosarcoma cells |
| Q37428692 | miR-203, a tumor suppressor frequently down-regulated by promoter hypermethylation in rhabdomyosarcoma. |
| Q27331653 | p53 suppresses muscle differentiation at the myogenin step in response to genotoxic stress |
Search more.